Postpartum anti-D: Can we safely reduce the dose?

Bradley M. Augustson, Elizabeth A. Fong, Dianne E. Grey, Janine I. Davies, Wendy N. Erber

    Research output: Contribution to journalArticlepeer-review

    17 Citations (Scopus)

    Abstract

    Objective: To assess the potential for dose-reduction of prophylactic anti-D postpartum. Design: Retrospective audit of fetomaternal haemorrh age (FMH) quantitation by flow cytometry. Participants and setting: 5148 consecutive Rhesus D-negative women aged 15-45 years who had FMH estimation by flow cytometry at a central laboratory in Western Australia in the 65 months between 1 August 1999 and 31 January 2005. Main outcome measures: Quantitation of FMH volume for adequate prophylactic anti-D administration in a timely fashion. Results: 90.4% (4651/5148) of the women had an FMH volume of 1.0 mL or less of Rh D-positive red cells, and 98.5% (5072/5148) had a volume of less than 2.5 mL. Only 0.4% of cases had an FMH volume of 6.0 mL or greater (range, 6.0-92.4 mL). Conclusions: This large retrospective aud it shows that a currently available dose of 250 IU (50 mg) of anti-D would have been sufficient for 98.5% of the 5148 Rh D-negative women. On the basis of this evidence, a reduction in the recommended routine postpartum dose of anti-D from 625 IU to 250 IU when flow cytometric quantitation for FMH is available should be considered. Adopting such a strategy would ensure the ongoing provision of a valuable human blood product currently in limited supply.

    Original languageEnglish
    Pages (from-to)611-613
    Number of pages3
    JournalMedical Journal of Australia
    Volume184
    Issue number12
    Publication statusPublished - 19 Jun 2006

    Fingerprint

    Dive into the research topics of 'Postpartum anti-D: Can we safely reduce the dose?'. Together they form a unique fingerprint.

    Cite this